Works matching IS 09395555 AND DT 2023 AND VI 102 AND IP 3
Results: 22
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 683, doi. 10.1007/s00277-023-05104-w
- By:
- Publication type:
- Article
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 583, doi. 10.1007/s00277-023-05103-x
- By:
- Publication type:
- Article
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 541, doi. 10.1007/s00277-023-05102-y
- By:
- Publication type:
- Article
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 529, doi. 10.1007/s00277-023-05097-6
- By:
- Publication type:
- Article
Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 629, doi. 10.1007/s00277-023-05093-w
- By:
- Publication type:
- Article
Real-world treatments and thrombotic events in polycythemia vera patients in the USA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 571, doi. 10.1007/s00277-023-05089-6
- By:
- Publication type:
- Article
Venetoclax-based combination therapy in R/R DLBCL patients with failure of CAR-T therapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 597, doi. 10.1007/s00277-023-05088-7
- By:
- Publication type:
- Article
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 547, doi. 10.1007/s00277-023-05087-8
- By:
- Publication type:
- Article
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 503, doi. 10.1007/s00277-023-05086-9
- By:
- Publication type:
- Article
Autologous stem cell transplantation in multiple myeloma patients with renal impairment.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 621, doi. 10.1007/s00277-023-05085-w
- By:
- Publication type:
- Article
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 651, doi. 10.1007/s00277-023-05084-x
- By:
- Publication type:
- Article
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 669, doi. 10.1007/s00277-023-05083-y
- By:
- Publication type:
- Article
GP1BB c.179C > T is the most frequent cause of monoallelic Bernard–Soulier syndrome in the Italian population after the Bolzano variant: a report of two new families.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 677, doi. 10.1007/s00277-022-05079-0
- By:
- Publication type:
- Article
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 613, doi. 10.1007/s00277-022-05077-2
- By:
- Publication type:
- Article
Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 687, doi. 10.1007/s00277-022-05076-3
- By:
- Publication type:
- Article
Can we lower the platelet threshold of ≥ 50 × 10<sup>9</sup>/L for performing a lumbar puncture safely in patients with hematological malignancies?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 663, doi. 10.1007/s00277-022-05073-6
- By:
- Publication type:
- Article
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 641, doi. 10.1007/s00277-022-05070-9
- By:
- Publication type:
- Article
Thyrotoxicosis after unrelated cord blood transplantation for adults.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 673, doi. 10.1007/s00277-022-05068-3
- By:
- Publication type:
- Article
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 681, doi. 10.1007/s00277-022-05067-4
- By:
- Publication type:
- Article
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 603, doi. 10.1007/s00277-022-05051-y
- By:
- Publication type:
- Article
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 563, doi. 10.1007/s00277-022-05024-1
- By:
- Publication type:
- Article
Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 519, doi. 10.1007/s00277-022-05007-2
- By:
- Publication type:
- Article